Expand SAGE Menu
SAGE MENU

SAGE Latest Press Releases

-- March 12, 2025 --

Long-Term Shareholder Notice: Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf Globe Newswire 8:26 AM

-- March 10, 2025 --

Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf as Certain Class Actions Move Forward Globe Newswire 8:05 AM

-- March 4, 2025 --

Sage Therapeutics Announces R&D Leadership Transition Business Wire 4:15 PM

-- February 11, 2025 --

Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates Business Wire 4:05 PM

-- January 28, 2025 --

Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025 Business Wire 4:30 PM

-- January 27, 2025 --

Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen's Unsolicited Acquisition Proposal Business Wire 9:20 AM

-- January 24, 2025 --

Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm Globe Newswire 1:38 PM

-- January 12, 2025 --

Sage Therapeutics to Present 2025 Strategic Focus at 43rd Annual J.P. Morgan Healthcare Conference Business Wire 6:00 PM

-- January 10, 2025 --

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen Business Wire 6:49 PM

-- January 8, 2025 --

Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 Business Wire 6:30 AM

-- November 26, 2024 --

Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference Business Wire 7:00 AM

-- November 20, 2024 --

Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington's Disease Business Wire 6:30 AM

-- October 29, 2024 --

Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates Business Wire 4:05 PM

-- October 28, 2024 --

SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:14 PM
Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE PRNewswire 10:10 AM
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 10:00 AM
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class Action - SAGE PRNewswire 5:45 AM

-- October 26, 2024 --

SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit PRNewswire 3:20 PM

-- October 25, 2024 --

SAGE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action SAGE Globe Newswire 12:41 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE PRNewswire 12:00 PM
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE) Business Wire 12:00 PM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics PRNewswire 9:55 AM

-- October 24, 2024 --

SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit PRNewswire 8:02 PM
SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors of the October 28, 2024 Lead Plaintiff Deadline in Class Action Lawsuits Filed on Behalf of Verve Therapeutics, Inc. (VERV), Sage Therapeutics, Inc. (SAGE), and Outset Medical, Inc. (OM) Shareholders Globe Newswire 1:42 PM

-- October 23, 2024 --

Sage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion Globe Newswire 8:06 PM
Rosen Law Firm Urges Sage Therapeutics, Inc. (NASDAQ: SAGE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Business Wire 12:58 PM
Investors who lost money on Sage Therapeutics, Inc. (SAGE) should contact The Gross Law Firm about pending Class Action - SAGE Globe Newswire 12:23 PM
DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:08 PM
Faruqi & Faruqi Reminds Sage Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE Globe Newswire 10:04 AM
Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE PRNewswire 10:00 AM
Sage Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - SAGE PRNewswire 5:45 AM

-- October 22, 2024 --

SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit PRNewswire 11:05 PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, Starbucks, Endava, and Sage and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
SAGE DEADLINE NOTICE: Rosen, A HIGHLY RECOGNIZED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action SAGE Globe Newswire 7:35 PM
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
DEADLINE ALERT for MEI, DAVA, OM, SAGE: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 3:33 PM

-- October 21, 2024 --

Sage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion Globe Newswire 4:43 PM
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit PRNewswire 4:17 PM
SAGE THERAPEUTICS, INC. (NASDAQ: SAGE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Sage Therapeutics, Inc. Investors of Upcoming Deadline Globe Newswire 7:45 AM
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 5:49 AM

-- October 19, 2024 --

SAGE DEADLINE: RLF, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action SAGE Globe Newswire 9:45 PM
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics PRNewswire 11:15 AM

-- October 18, 2024 --

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE) Globe Newswire 12:00 PM

-- October 17, 2024 --

ROSEN, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action SAGE Globe Newswire 8:42 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE PRNewswire 1:41 PM
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit PRNewswire 12:00 PM
Sage Therapeutics Announces Strategic Reorganization to Prioritize ZURZUVAE Commercialization and Focus its Development Portfolio Business Wire 7:00 AM
Shareholders of Sage Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - SAGE PRNewswire 5:45 AM

-- October 16, 2024 --

SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:07 PM
The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 SAGE Globe Newswire 11:42 AM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics Globe Newswire 10:24 AM

-- October 15, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit PRNewswire 4:09 PM
DEADLINE ALERT for MEI, DAVA, OM, SAGE: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:00 PM
Sage Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024 Business Wire 6:30 AM
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More PRNewswire 5:45 AM

-- October 14, 2024 --

Shareholders that lost money on Sage Therapeutics, Inc. (SAGE) Urged to Join Class Action Contact Levi & Korsinsky to Learn More Globe Newswire 1:23 PM
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics PRNewswire 10:15 AM
SAGE THERAPEUTICS, INC. (NASDAQ: SAGE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Sage Therapeutics, Inc. Investors of Upcoming Deadline Globe Newswire 8:15 AM
Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class Action - SAGE PRNewswire 5:55 AM